Bill Ackman Pershing Square Capital Management
Bill Ackman is the founder and CEO of Pershing Square Capital Management, a New York–based hedge fund. He employs an activist investing approach, seeking to influence the management and direction of the publicly traded companies in which he invests. Frequently in the public eye, Ackman has been noted for both high-profile successes and controversies, such as his well-known short position in Herbalife.
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.91% |
| 2 | Materials | 27.03% |
| 3 | Industrials | 15.46% |
| 4 | Consumer Discretionary | 10.05% |
| 5 | Real Estate | 3.55% |
Similar funds
Bill Ackman's Q2 2015 Portfolio in Review
As of Q2 2015, Bill Ackman held 8 positions worth $14.4B, down 3.5% from $15B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Bill Ackman's Q2 2015 filing shows 1 closed position. The largest sale was Allergan plc, an estimated $401M.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 41% a quarter earlier, followed by Materials and Industrials.
- Bill Ackman fully exited Allergan plc in Q2 2015, selling an estimated $401M.
- Bill Ackman's ten largest holdings make up 100% of its $14.4B portfolio in Q2 2015.
- Bill Ackman opened 0 new positions and closed 1 in Q2 2015.
- Bill Ackman's portfolio value fell 3.5% quarter-over-quarter to $14.4B.
Based on Pershing Square Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.